Variant report
Variant | nsv528289 |
---|---|
Chromosome Location | chr9:1446459-1450428 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4741361 | chr9:1446459-1446460 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs181941366 | chr9:1446460-1446461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554983503 | chr9:1446493-1446494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575235972 | chr9:1446502-1446503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78857339 | chr9:1446503-1446504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9406477 | chr9:1446522-1446523 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs571769490 | chr9:1446640-1446641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534318772 | chr9:1446663-1446664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553191482 | chr9:1446707-1446708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140129904 | chr9:1446733-1446734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541732026 | chr9:1446772-1446773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75413541 | chr9:1446779-1446780 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575090249 | chr9:1446787-1446788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543801602 | chr9:1446825-1446826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540309683 | chr9:1446890-1446891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546377476 | chr9:1446912-1446913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563766621 | chr9:1446917-1446918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564871745 | chr9:1446920-1446921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75309834 | chr9:1446942-1446943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539952853 | chr9:1446944-1446945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10961494 | chr9:1446964-1446965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529490081 | chr9:1446975-1446976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549368092 | chr9:1446984-1446985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569527246 | chr9:1446988-1446989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10122783 | chr9:1447011-1447012 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs560521260 | chr9:1447032-1447033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184608781 | chr9:1447046-1447047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190112691 | chr9:1447053-1447054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181783898 | chr9:1447055-1447056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554330316 | chr9:1447065-1447066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186520818 | chr9:1447080-1447081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9406478 | chr9:1447107-1447108 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs555319096 | chr9:1447120-1447121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149813770 | chr9:1447161-1447162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537781888 | chr9:1447162-1447163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557295633 | chr9:1447166-1447167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531078218 | chr9:1447183-1447184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs114206007 | chr9:1447185-1447186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539892492 | chr9:1447196-1447197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560200426 | chr9:1447218-1447219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573693360 | chr9:1447250-1447251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs535077612 | chr9:1447274-1447275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145885932 | chr9:1447294-1447295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373722527 | chr9:1447310-1447311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191427421 | chr9:1447318-1447319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546449375 | chr9:1447335-1447336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532018434 | chr9:1447339-1447340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552121493 | chr9:1447384-1447385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370401777 | chr9:1447395-1447396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs77035763 | chr9:1447396-1447397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1415400-1452800 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1446200-1447000 | Enhancers | Fetal Lung | lung |